Publication:
The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer

Simple item page
dc.contributor.authorTerzioglu-Usak, Sule
dc.contributor.authorHorozoglu, Cem
dc.contributor.authorDemirkol, Seyda
dc.contributor.authorTurna, Akif
dc.contributor.authorYaylim, Ilhan
dc.contributor.institutionauthorTERZİOĞLU, ŞULE
dc.date.accessioned2021-05-25T20:59:16Z
dc.date.available2021-05-25T20:59:16Z
dc.date.issued2021-04-01T00:00:00Z
dc.description.abstractBackground: The aim of this study was to investigate the possible relationship between galectin-3 gene variants, serum level, gene expression level, and the risks and survivals of resectable non-small cell lung cancer patients.
dc.identifier.citationTerzioglu-Usak S., Horozoglu C., Demirkol S., Turna A., Yaylim I., -The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer-, TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.29, sa.2, ss.212-222, 2021
dc.identifier.doi10.5606/tgkdc.dergisi.2021.20141
dc.identifier.pubmed34104515
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28922
dc.identifier.wosWOS:000645197100011
dc.titleThe role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer
dc.typeArticle
dspace.entity.typePublication
local.avesis.idfe9ba32b-6080-4b7b-b7f9-a43b342182aa
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublicatione9c5ccbe-e102-4178-b519-106941fe5827
relation.isAuthorOfPublication.latestForDiscoverye9c5ccbe-e102-4178-b519-106941fe5827
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler